Health technology is an exciting, expanding frontier that promises a better life for everyone
The regulation few outside of pharma have heard about
Biologics promise targeted treatments for a range of conditions – if we can overcome the technological challenges
Following the recent acquisition of the world-leading Materia catalyst business by Umicore, we’ve been granted an exclusive interview with Robert Grubbs, chemistry Nobel laureate and co-founder of Materia.
The history of cisplatin, the drug that is still the gold – or should that be platinum? – standard in cancer drugs
Less toxic than quantum dots, can conjugated polymer nanoparticles revolutionise bioimaging?
The future of wearable gadgets will be tiny, flexible, skin-like devices capable of monitoring your health